Other authors found that EVs from adriamycin-resistant breast cancer cells contained high amounts of glutathione S-transferase P1 (GSTP1, a phase II metabolic enzyme capable of detoxifying damaging chemicals from cells), which was transferred to sensitive cells. The gene discussed is GSTP1; the disease is breast cancer.